Literature DB >> 2667369

Clinical indications for and procedures associated with penetrating keratoplasty, 1983-1988.

S E Brady1, C J Rapuano, J J Arentsen, E J Cohen, P R Laibson.   

Abstract

We reviewed the preoperative clinical indications and associated surgical procedures for 2,299 penetrating keratoplasties performed at our institution from 1983 through 1988. Pseudophakic bullous keratopathy was the most common indication overall, accounting for 526 cases (23%). A marked increase was noted in the incidence of pseudophakic bullous keratopathy as an indication for penetrating keratoplasty beginning in 1985. The association of anterior chamber intraocular lenses in eyes with pseudophakic bullous keratopathy undergoing penetrating keratoplasty increased from 19 of 43 cases (44%) in 1983 to 79 of 108 cases (73%) in 1988. The incidence of intraocular lens exchange at the time of penetrating keratoplasty in cases of pseudophakic bullous keratopathy increased from six of 43 (14%) in 1983 to 63 of 108 (58%) in 1988. Other major indications for penetrating keratoplasty included Fuchs' dystrophy (375 cases, 16%), keratoconus (348 cases, 15%), aphakic bullous keratopathy (331 cases, 14%), and regraft (233 cases, 10%). Cataract extraction, with or without intraocular lens implantation, was combined with penetrating keratoplasty in 397 of 1,532 phakic eyes (26%). The incidence of triple procedure (penetrating keratoplasty, cataract extraction, and intraocular lens implantation) increased from 27 of 248 phakic eyes (11%) in 1983 to 68 of 258 phakic eyes (26%) in 1988.

Entities:  

Mesh:

Year:  1989        PMID: 2667369     DOI: 10.1016/0002-9394(89)90003-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  22 in total

1.  Cell subpopulations in failed human corneal grafts.

Authors:  L Kuffová; V Holán; L Lumsden; J V Forrester; M Filipec
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

2.  Penetrating keratoplasty: indications over a 10 year period.

Authors:  N Al-Yousuf; I Mavrikakis; E Mavrikakis; S M Daya
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

3.  Combined penetrating keratoplasty and posterior chamber intraocular lens implantation in the absence of a lens capsule.

Authors:  R N Gaster; R C Troutman; H V Ong; A Draga; S C Belmont
Journal:  Trans Am Ophthalmol Soc       Date:  1990

4.  Indications for penetrating keratoplasty in East China, 1994-2003.

Authors:  Chaoran Zhang; Jianjiang Xu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

Review 5.  Trends in penetrating keratoplasty in the United States 1980-2005.

Authors:  Faris R Ghosheh; Federico A Cremona; Christopher J Rapuano; Elisabeth J Cohen; Brandon D Ayres; Kristin M Hammersmith; Irving M Raber; Peter R Laibson
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

Review 6.  Adult keratoplasty: has the prognosis improved in the last 25 years?

Authors:  Francis W Price; Marianne O Price
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

7.  Triple procedure; analysis of outcome, refraction, and intraocular lens power calculation.

Authors:  A J Geerards; E Hassmann; W H Beekhuis; L Remeyer; G van Rij; W J Rijneveld
Journal:  Br J Ophthalmol       Date:  1997-09       Impact factor: 4.638

8.  Adhesion molecule expression in bullous keratopathy.

Authors:  S N Zhu; B Nölle; G Duncker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

Review 9.  Cell death and the immune response: a lesson from the privileged.

Authors:  T A Ferguson; T S Griffith
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

10.  Long-term symptomatic relief of bullous keratopathy with amniotic membrane transplant.

Authors:  Gillian D J Y Siu; Alvin L Young; Lulu L Cheng
Journal:  Int Ophthalmol       Date:  2015-01-14       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.